Prediction of absorbed dose by tumors and critical organs after Lu-177-DOTATATE therapy using pretherapeutic Ga-68-DOTATOC PET/CT

被引：0
|
作者：
Kim, Yong-il [1 ]
Oh, Jungsu [1 ]
Yoo, Changhoon [1 ]
Ryoo, Baek-Yeol [1 ]
Ryu, Jin-Sook [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
76
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparison of 68Ga-DOTATATE PET/CT for Assessment of Response to Peptide Receptor Radionuclide Therapy after 2 and 4 Cycles of 177Lu-DOTATATE: Preliminary Single Academic Center Experience
    Song, H.
    Kunz, P.
    Fisher, G.
    Franc, B.
    Moradi, F.
    Davidz, G.
    Iag, A.
    Aparic, Mari C.
    NEUROENDOCRINOLOGY, 2020, 110 : 273 - 273
  • [32] Evaluation of Kidney Dose in Neuroendocrine Tumors Patients after Peptide Receptor Radionuclide Therapy using 177Lu-DOTATATE
    Hidayati, N. R.
    Poon, A.
    Willowson, K.
    Eslick, E.
    Ryu, H.
    Bailey, D. L.
    ATOM INDONESIA, 2019, 45 (03) : 147 - 152
  • [33] Subacute and Long-Term Hepatotoxicity Risk after 90Y-OR 177LU-DOTATOC Therapy - Is Hepatic Tumour Burden on 68Ga-DOTATOC PET/CT Predictive of Liver Dysfunction?
    Chirindel, A.
    Anongpornjossakul, Y.
    Wild, D.
    Nicolas, G.
    NEUROENDOCRINOLOGY, 2019, 108 : 204 - 204
  • [34] Comparison of the tracer uptake into the kidneys in GA68-PSMA-PET-CT and the absorbed dose per applied GBq Lu177-PSMA-617 during a following therapy
    Wichert, Jennifer
    Groener, Daniel
    Happel, Christian
    Vogl, Thomas
    Mandel, Pilipp
    Ngoc, Christina Nguyen
    Tselis, Nikolaos
    Gruenwald, Frank
    Sabet, Amir
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [35] The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
    Duygu Has Simsek
    Yunus Guzel
    Dilara Denizmen
    Yasemin Sanli
    Fikret Buyukkaya
    Bilal Kovan
    Halil Komek
    Emine Goknur Isik
    Zeynep Gozde Ozkan
    Serkan Kuyumcu
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 828 - 840
  • [36] The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
    Simsek, Duygu Has
    Guzel, Yunus
    Denizmen, Dilara
    Sanli, Yasemin
    Buyukkaya, Fikret
    Kovan, Bilal
    Komek, Halil
    Isik, Emine Goknur
    Ozkan, Zeynep Gozde
    Kuyumcu, Serkan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 828 - 840
  • [37] Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors A Feasibility Study
    Thuillier, Philippe
    Maajem, Meriem
    Schick, Ulrike
    Blanc-Beguin, Frederique
    Hennebicq, Simon
    Metges, Jean-Philippe
    Salaun, Pierre-Yves
    Kerlan, Veronique
    Bourhis, David
    Abgral, Ronan
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (02) : 111 - 118
  • [38] Quality of life (QoL) benefits following 177Lu-DOTATATE therapy in patients (pts) with 68Ga-DOTATATE PET positive primary site agnostic neuroendocrine tumors (NET)
    Wong, Rebecca K. S.
    Myrehaug, Sten
    Juergens, Rosalyn A.
    Laidley, David
    Ezzat, Shereen
    Beauregard, Jean-Mathieu
    Levine, Oren Hannun
    Veit-Haibach, Patrick
    Metser, Ur
    Driscoll, Brandon
    Shessel, Andrea
    Yeung, Ivan
    Mesci, Aruz
    Publicover, Julia
    Sun, Edward
    Lajkosz, Katherine
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] A False-Negative 123I-MIBG SPECT/CT With True-Positive 68Ga-DOTATATE PET/CT in a Patient With Neuroblastoma Following 177Lu-DOTATATE Therapy
    Li, Siqi
    Xu, Yanfeng
    Lu, Xia
    Wang, Wei
    Yang, Jigang
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (01) : 72 - 74
  • [40] Gastroenteropancreatic Neuroendocrine Tumors: Standardizing Therapy Monitoring with 68Ga-DOTATOC PET/CT Using the Example of Somatostatin Receptor Radionuclide Therapy
    Luboldt, Wolfgang
    Hartmann, Holger
    Wiedemann, Baerbel
    Zoephel, Klaus
    Luboldt, Hans-Joachim
    MOLECULAR IMAGING, 2010, 9 (06) : 351 - 358
12345